A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26095918.
- Also identified by DOI 10.1038/ncomms8316 and PMC identifier 4557300.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
PIWI-interacting RNAs (piRNAs) are thought to silence transposon and gene expression during development. However, the roles of piRNAs in somatic tissues are largely unknown. Here we report the identification of 555 piRNAs in human lung bronchial epithelial (HBE) and non-small cell lung cancer (NSCLC) cell lines, including 295 that do not exist in databases termed as piRNA-like sncRNAs or piRNA-Ls. Distinctive piRNA/piRNA-L expression patterns are observed between HBE and NSCLC cells. piRNA-like-163 (piR-L-163), the top downregulated piRNA-L in NSCLC cells, binds directly to phosphorylated ERM proteins (p-ERM), which is dependent on the central part of UUNNUUUNNUU motif in piR-L-163 and the RRRKPDT element in ERM. The piR-L-163/p-ERM interaction is critical for p-ERM's binding capability to filamentous actin (F-actin) and ERM-binding phosphoprotein 50 (EBP50). Thus, piRNA/piRNA-L may play a regulatory role through direct interaction with proteins in physiological and pathophysiological conditions.
Medical subject headings
- Actins
- Carcinoma, Non-Small-Cell Lung
- Cytoskeletal Proteins
- Lung Neoplasms
- Membrane Proteins
- Microfilament Proteins
- Phosphoproteins
- RNA, Small Interfering
- Respiratory Mucosa
- Sodium-Hydrogen Exchangers